Elysium Health™ Officially Opens The Elysium Longevity Institute™ (TELI), Establishing a New Standard for Longevity Medicine

From the leader in longevity science, TELI brings together personalized, physician-led care, uncompromising quality and safety standards, and a commitment to advancing clinical research

NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Elysium Health, Inc.™, the leading longevity science company, today announced the opening of The Elysium Longevity Institute™ (TELI), marking the company's most significant milestone since its launch in 2015 and establishing a new standard for personalized, physician-led longevity medicine. TELI reflects a growing consumer demand for a more rigorous approach to longevity care—one built on physician oversight, uncompromising quality and safety standards, and a commitment to advancing clinical research. Members can access personalized longevity protocols that integrate prescription therapies, supplements, peptides, and ongoing clinical care through a single, comprehensive program. Grounded in the scientific rigor that has defined Elysium for more than a decade, TELI is led by Chief Medical Officer Omar Baker, M.D., F.A.A.P., in collaboration with Elysium co-founder, Chief Scientist, and Novartis Professor of Biology at MIT Leonard Guarente, Ph.D.

Dr. Baker brings nearly 15 years of experience spanning clinical care, healthcare innovation, and executive leadership. Most recently, as Executive Vice President and Deputy Chief Medical Officer at UnitedHealth Group, the world's largest health care company, he helped shape clinical strategy and innovation at scale—experience that now informs Elysium's vision for the future of longevity medicine.

"Longevity medicine has reached an inflection point—scientific advances are arriving faster than ever before," said Dr. Baker. "These advances raise the standard for how they should be delivered. Responsible longevity medicine isn't defined by access to a particular therapy. It's defined by thoughtful clinical judgment, individualized care, and rigorous quality standards. People want to understand which interventions are appropriate for them, how those interventions work together, and how their care should evolve as their health changes. Pairing those principles with a commitment to generating new clinical evidence creates a model that can advance both patient care and the field itself. That's the philosophy behind The Elysium Longevity Institute. We believe it's the future of longevity medicine—and the standard every patient deserves."

The Elysium Longevity Institute provides a personalized, physician-led longevity program designed to optimize healthspan and lifespan through ongoing clinical care. Following a comprehensive medical intake, licensed providers develop individualized protocols tailored to each person's medical history, lifestyle factors, and health goals. With ongoing clinical care, protocols are adjusted according to the individual's response to treatment over time and as their health, lifestyle, or goals change. At launch, the program includes 18 longevity-focused protocols, including prescription medications, peptides, supplements, and vitamins in oral, intranasal, and injectable forms, with ongoing clinical support and personalized treatment adjustments throughout.

"For decades, the goal of aging research was to understand why we age," said Elysium Chief Scientist and Novartis Professor of Biology at MIT Leonard Guarente, Ph.D. "Today, we're entering a new era where many of those discoveries are beginning to translate into interventions that may actually help people live healthier, longer lives. The next challenge is ensuring those discoveries are translated responsibly into clinical practice while continuing to generate the evidence that moves the field forward. The Elysium Longevity Institute represents an important step toward making that vision a reality."

"When we launched Elysium in 2015, our mission was to bring the world's best aging research out of the lab and into people's lives," said Elysium co-founder and CEO Eric Marcotulli. "Over the past decade, we've helped define new categories in longevity, supported more than 20 clinical trials, and demonstrated that scientific rigor and commercial innovation can go hand in hand. Our responsibility isn't simply to make the latest advances in longevity science available—it's to evaluate them rigorously, deliver them responsibly, and continue contributing to the evidence that shapes the future of longevity medicine. That's the standard we've worked to uphold for more than a decade, and it's the standard that will define the Institute."

The Elysium Longevity Institute is open to eligible patients in the United States. Individuals can learn more, complete a comprehensive medical intake, and begin personalized, physician-led longevity care at elysiumhealthrx.com. While TELI launches with 18 longevity-focused protocols, Elysium will continue expanding its clinical offerings as the science advances and new therapies become available. Consistent with the company's longstanding commitment to science, uncompromising quality and safety standards, and advancing clinical evidence, every new protocol will be evaluated with the same rigor that Elysium has applied since 2015.

About Elysium Health™

Elysium Health's™ mission is to solve the biggest challenges in health with science, to help people lead healthier lives. Working directly with the world's leading scientists and clinicians, Elysium Health™ is committed to translating critical advancements in aging research into health solutions people can access today. Elysium Health™ is backed by General Catalyst, Morningside Ventures, Breyer Capital, Mayo Clinic Ventures, and other notable investors. Learn more at elysiumhealth.com.

SOURCE Elysium Health